ADRC001

DRUG3 trials

Sponsors

Odense University Hospital, Copenhagen University Hospital, Rigshospitalet

Conditions

Crypto-glandular perianal fistulaHypertrophic scarring.Xerostomia due to readiotherapy for a head & neck cancer

Phase 1

Repairing Peri-Anal Fistulas with regenerative cell therapeutics (REP-PAF)

RecruitingCTIS2022-502659-73-01

Odense University HospitalCrypto-glandular perianal fistula

Start: 2024-10-09Target: 75Updated: 2025-09-22

Scar Remodeling after Burn Injury using Adipose-derived Allogeneic Stem Cells (ScarASC)

Not yet recruitingCTIS2024-519160-41-00

Copenhagen University HospitalHypertrophic scarring.

Target: 39Updated: 2025-08-19

Phase 2

Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors

Not yet recruitingCTIS2025-522559-25-00

RigshospitaletXerostomia due to readiotherapy for a head & neck cancer

Target: 100Updated: 2025-09-08

Related Papers

Repairing Peri-Anal Fistulas with regenerative cell therapeutics: study protocol for a double-blinded randomized controlled phase I–II trial from Denmark (REP-PAF)

Trials2026-03-04